At a glance
- Originator Pharmacia Corporation
- Class Antibacterials; Oxazolidinones
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 06 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 02 Nov 1998 Preclinical development for Bacterial infections in USA (Unknown route)
- 20 Oct 1998 New profile